CATERBI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.250
EU - Europa 829
AS - Asia 804
SA - Sud America 166
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.063
Nazione #
US - Stati Uniti d'America 1.229
SG - Singapore 375
IE - Irlanda 205
BR - Brasile 145
CN - Cina 127
RU - Federazione Russa 121
IT - Italia 118
HK - Hong Kong 117
VN - Vietnam 117
DE - Germania 67
FR - Francia 62
SE - Svezia 62
UA - Ucraina 61
FI - Finlandia 40
GB - Regno Unito 28
KR - Corea 24
AT - Austria 21
CZ - Repubblica Ceca 17
CA - Canada 10
AR - Argentina 7
ES - Italia 7
JP - Giappone 7
MX - Messico 7
BD - Bangladesh 6
EC - Ecuador 6
ZA - Sudafrica 6
BE - Belgio 4
IN - India 4
PL - Polonia 4
TR - Turchia 4
UZ - Uzbekistan 4
CH - Svizzera 3
CO - Colombia 3
ID - Indonesia 3
IL - Israele 3
NL - Olanda 3
PK - Pakistan 3
JO - Giordania 2
NP - Nepal 2
PE - Perù 2
VE - Venezuela 2
ZW - Zimbabwe 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BB - Barbados 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
IQ - Iraq 1
KE - Kenya 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 3.063
Città #
Chandler 268
Singapore 238
Dublin 204
San Mateo 119
Hong Kong 108
Dong Ket 71
Ashburn 63
Perugia 62
Boardman 52
Santa Clara 48
Medford 44
Princeton 43
Altamura 37
Munich 37
Lawrence 36
Wilmington 36
Andover 34
Beijing 34
Moscow 34
Jacksonville 28
Seoul 23
Ann Arbor 22
Vienna 20
Los Angeles 18
Ho Chi Minh City 15
Saint Petersburg 15
Dallas 14
São Paulo 14
Brno 13
Hanoi 13
Des Moines 12
Helsinki 11
Norwalk 11
New York 10
San Paolo di Civitate 10
Falls Church 9
Atlanta 8
Houston 7
The Dalles 7
Tokyo 7
Ottawa 6
Redwood City 6
Denver 5
Kensington 5
Rio de Janeiro 5
Stockholm 5
Boston 4
Brooklyn 4
Brussels 4
London 4
Olomouc 4
Phoenix 4
Turku 4
Biên Hòa 3
Brasília 3
Cachoeiras de Macacu 3
Campo Grande 3
Chengdu 3
Chicago 3
Columbus 3
Guangzhou 3
Guarulhos 3
Haiphong 3
Izmir 3
Johannesburg 3
Mexico City 3
Montreal 3
Nuremberg 3
Redmond 3
Warsaw 3
Amman 2
Anápolis 2
Bogotá 2
Caxias do Sul 2
Charlotte 2
Curitiba 2
Da Nang 2
Den Haag 2
Duque de Caxias 2
Falkenstein 2
Fremont 2
Guayaquil 2
Harare 2
Hefei 2
Itabaiana 2
Macaé 2
Milan 2
Mumbai 2
Orem 2
Piscataway 2
Poplar 2
Pretoria 2
Recife 2
San Francisco 2
Seattle 2
Secaucus 2
Shanghai 2
Sumaré 2
São Vicente 2
Tappahannock 2
Totale 2.026
Nome #
Development of virulence-attenuated Plasmodium berghei parasites 128
Disruption of plasmepsin-4 and merozoites surface protein-7 genes in Plasmodium berghei induces combined virulence-attenuated phenotype 106
Plasmepsin 4 Deficient Plasmodium berghei Are Virulence-Attenuated and Induce Protective Immunity against Experimental Malaria 98
Plasmepsin 4 deficient Plasmodium berghei are virulence-attenuated and induce protective immunity against experimental malaria 96
IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. 95
Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sjögren's syndrome: new markers of chronic endothelial damage? 95
Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New 95
Sequential disruption of the blood stage genes Plasmepsin 4 and MSP7 in Plasmodium berghei induces a progressively virulence-attenuated phenotype 93
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study. 92
A8. 6 A novel therapeutic approach in systemic rheumatic autoimmune disorders: encapsulated human umbilical cord wharton jelly-derived mesenchymal stem cells 91
Sequential disruption of PM4 and MSP7 in Plasmodium berghei induces a progressive virulence-attenuated phenotype. 88
The circulating interferon-inducible protein IFI16 correlates with clinical and serological features in Rheumatoid Arthritis 86
Circulating interferon-inducible protein IFI16 correlates with clinical and serological features in rheumatoid arthritis. 84
PROTEIN EXPRESSION PROFILE OF PLASMEPSIN IV KNOCK DOWN PLASMODIUM BERGHEI PARASITE AND IMMUNOREACTIVE IDENTIFICATION 83
Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic Implications. 83
Anticyclic Citrullinated Peptide Antibodies in Patients with Rheumatic Diseases other than Rheumatoid Arthritis: Clinical or Pathogenic Significance? 81
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives 81
GALACTOXYLOMANNAN IS A POWERFUL IMMUNE SYSTEM MODULATOR ABLE TO REBALANCE TREG/TH17 RATIO IN RHEUMATOID ARTHRITIS 80
Serum interleukin-17 in primary Sjögren's syndrome: association with disease duration and parotid gland swelling. 80
Characterization of a new regulatory CD4+ T cell subset in primary Sjogren's syndrome. 79
Circulating Endothelial Microparticles and Endothelial Progenitors Cells in Primary SjÖGren's Syndrome: New Markers of Chronic Endothelial Damage? 77
Association between clinical, histopathological and molecular features in primary Sjögren’s Syndrome: a retrospective study 76
IL-17 producing-DN T cells are expanded in the blood, infiltrate salivary glands and are resistant to corticosteroids in sjÖgren’s syndrome 74
Plasmepsin 4 Deficient Plasmodium berghei Are Virulence-Attenuated and Induce Protective Immunity against Experimental Malaria 73
A6.2 Purified microbial capsular polysaccharide Galactoxylomannan (GalXM) inhibits the effector T lymphocyte arm and potentiates the regulatory counterpart in rheumatoid arthritis 73
Endothelial Microparticles and Circulating Endothelial Progenitor Cells in Primary SjöGren’s Syndrome Patients: Correlation with Clinical and Immunological Features 71
Restoration of t cell substes of patients with type 1 diabetes mellitus by microencapsulated human umbilical cord wharton jelly-derived mesenchymal stem cells: An in vitro study 70
Immunomodulatory effects of human umbilical cord wharton jelly-derived mesenchymal stem cells (HUCMS) on circulating T-cell subsets in patients with sjögren’s syndrome 69
CD4-CD8- T-cells in primary Sjögren's syndrome: Association with the extent of glandular involvement 65
Telocytes in minor salivary glands of primary Sjögren's syndrome: Association with the extent of inflammation and ectopic lymphoid neogenesis 61
CD3+CD4–CD8–Double Negative Th17 Cells: New Insights in the Pathogenesis of Primary Sjögren’s Syndrome 61
IL-17 Producing Pathogenic T Lymphocytes Co-Express CD20 and are Depleted by Rituximab in Primary sjögren's Syndrome: A Novel Target for an Old Weapon 61
TELOCYTES IN MINOR SALIVARY GLANDS OF PATIENTS WITH PRIMARY SJOGREN'S SYNDROME: ASSOCIATION WITH THE EXTENT OF INFLAMMATION AND ECTOPIC LYMPHONEOGENESIS 57
Interferon gamma-inducible protein 16 in primary Sjögren's syndrome: a novel player in disease pathogenesis? 54
Interferon Gamma-Inducible Protein 16 (IFI16) in Primary SjÖgren's Syndrome: A Novel Player in Disease Pathogenesis? 54
The role of T helper 17 cell subsets in Sjogren's syndrome: similarities and differences between mouse model and humans 53
Mobilization of Lymphatic Endothelial Precursors Cells and Lymphatic Neovascularization in Primary Sjögren's Syndrome 52
Role of Platelets in the Pathogenesis of Osteoarthritis and Biological Effects of Hyaluronic Acid: in Vivo and in Vitro Study 49
Selective elimination of pathogenic TH17 cells from peripheral blood of rheumatoid arthritis patients by a purified fungal polysaccharide 49
Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 49
Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome 45
Interferon Gamma-Inducible Protein 16 (IFI16) in Rheumatoid Arthritis: A Novel Biomarker for Pulmonary Involvement? 43
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: A pilot study 33
Totale 3.183
Categoria #
all - tutte 15.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.215


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021136 0 0 0 0 0 12 10 4 17 6 13 74
2021/2022370 3 81 11 12 12 7 2 130 3 11 44 54
2022/2023720 45 147 4 81 54 70 0 37 250 0 21 11
2023/2024263 21 30 9 0 1 17 50 9 8 8 49 61
2024/2025580 20 64 16 47 85 12 10 19 119 39 111 38
2025/2026679 85 82 79 169 183 81 0 0 0 0 0 0
Totale 3.183